Error: Could not add to watchlist. X
+ Watchlist

Hemispherx Biopharma Inc

HEB:US
NYSE MKT LLC
0.495
USD
0.015
2.90%
As of 12:21 PM EDT 6/29/2017
Open
0.504
Day Range
0.490 - 0.510
Volume
9,864
Previous Close
0.510
52Wk Range
0.392 - 2.636
1 Yr Return
-63.76%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.504
Day Range
0.490 - 0.510
Volume
9,864
Previous Close
0.510
52Wk Range
0.392 - 2.636
1 Yr Return
-63.76%
YTD Return
-28.21%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.453
Market Cap (m USD)
13.029
Shares Outstanding (m)
26.589
Price/Sales (TTM)
88.41
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.86%
% Price Change
-1.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Address
1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
Phone
1-215-988-0080
  • Thomas K Equels
    Vice Chairman/Pres/CEO/Secy
  • Adam Pascale
    CFO/Chief Acctg Officer
  • David R Strayer
    Chief Scientific Ofcr/Dir:Medical
  • Carol A Smith
    Chief Manufacturing Ofcr
  • Wayne S Springate
    Senior VP:Operations
Show More